Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 1 | 1 | 17 | 33 |
| Other current assets | 0 | 178 | 53 | 0 | 49 |
| TOTAL | $23 | $209 | $85 | $45 | $121 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 3 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $3 |
| Total Assets | $23 | $209 | $85 | $45 | $124 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,724 | 5,236 | 4,924 | 3,772 | 3,303 |
| Accrued Expenses | 3,296 | 2,609 | 1,541 | 2,084 | 1,304 |
| TOTAL | $11,729 | $9,923 | $8,148 | $7,490 | $5,857 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 174 | 294 | 0 | 0 | 0 |
| TOTAL | $174 | $294 | $N/A | $N/A | $N/A |
| Total Liabilities | $11,903 | $10,217 | $8,148 | $7,490 | $5,857 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 144,327 | 97,894 | 89,497 | 3,369 | 387 |
| Common Shares | 126 | 98 | 71 | 0 | 4 |
| Retained earnings | -176,058 | -173,955 | -170,810 | -166,509 | -164,394 |
| Other shareholders' equity | 22 | 22 | 22 | 22 | 22 |
| TOTAL | $-11,880 | $-10,008 | $-8,063 | $-7,445 | $-5,733 |
| Total Liabilities And Equity | $23 | $209 | $85 | $45 | $124 |